Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Serotonergic antidepressants and increased bleeding risk in patients undergoing breast biopsy.

Mahdanian AA, Looper KJ, Bacon SL, Mesurolle B, Meterissian SH, Rej S.

Ther Adv Psychopharmacol. 2015 Dec;5(6):332-8. doi: 10.1177/2045125315612014.

2.

Impact of Rural Residence on Warfarin Use and Clinical Events in Patients with Non-Valvular Atrial Fibrillation: A Canadian Population Based Study.

Wu C, McMurtry MS, Sandhu RK, Youngson E, Ezekowitz JA, Kaul P, McAlister FA.

PLoS One. 2015 Oct 14;10(10):e0140607. doi: 10.1371/journal.pone.0140607. eCollection 2015.

3.

Validity of Diagnostic Codes for Acute Stroke in Administrative Databases: A Systematic Review.

McCormick N, Bhole V, Lacaille D, Avina-Zubieta JA.

PLoS One. 2015 Aug 20;10(8):e0135834. doi: 10.1371/journal.pone.0135834. eCollection 2015.

4.

Hospital variability in use of anticoagulant strategies during acute myocardial infarction treated with an early invasive strategy.

Arnold SV, Li SX, Alexander KP, Spertus JA, Nallamothu BK, Curtis JP, Kosiborod M, Gupta A, Wang TY, Lin H, Dharmarajan K, Strait KM, Lowe TJ, Krumholz HM.

J Am Heart Assoc. 2015 Jun 15;4(6):e002009. doi: 10.1161/JAHA.115.002009.

5.

Alcohol misuse, genetics, and major bleeding among warfarin therapy patients in a community setting.

Roth JA, Bradley K, Thummel KE, Veenstra DL, Boudreau D.

Pharmacoepidemiol Drug Saf. 2015 Jun;24(6):619-27. doi: 10.1002/pds.3769. Epub 2015 Apr 8.

6.

The three-year incidence of major hemorrhage among older adults initiating chronic dialysis.

Sood MM, Bota SE, McArthur E, Kapral MK, Tangri N, Knoll G, Zimmerman D, Garg AX.

Can J Kidney Health Dis. 2014 Sep 2;1:21. doi: 10.1186/s40697-014-0021-x. eCollection 2014.

7.

Validity of international classification of disease codes to identify ischemic stroke and intracranial hemorrhage among individuals with associated diagnosis of atrial fibrillation.

Thigpen JL, Dillon C, Forster KB, Henault L, Quinn EK, Tripodis Y, Berger PB, Hylek EM, Limdi NA.

Circ Cardiovasc Qual Outcomes. 2015 Jan;8(1):8-14. doi: 10.1161/CIRCOUTCOMES.113.000371. Epub 2015 Jan 13.

8.

Validity of claims-based stroke algorithms in contemporary Medicare data: reasons for geographic and racial differences in stroke (REGARDS) study linked with medicare claims.

Kumamaru H, Judd SE, Curtis JR, Ramachandran R, Hardy NC, Rhodes JD, Safford MM, Kissela BM, Howard G, Jalbert JJ, Brott TG, Setoguchi S.

Circ Cardiovasc Qual Outcomes. 2014 Jul;7(4):611-9. doi: 10.1161/CIRCOUTCOMES.113.000743. Epub 2014 Jun 24.

9.

Benefits and risks of anticoagulation resumption following traumatic brain injury.

Albrecht JS, Liu X, Baumgarten M, Langenberg P, Rattinger GB, Smith GS, Gambert SR, Gottlieb SS, Zuckerman IH.

JAMA Intern Med. 2014 Aug;174(8):1244-51. doi: 10.1001/jamainternmed.2014.2534.

10.

Serious bleeding events due to warfarin and antibiotic co-prescription in a cohort of veterans.

Lane MA, Zeringue A, McDonald JR.

Am J Med. 2014 Jul;127(7):657-663.e2. doi: 10.1016/j.amjmed.2014.01.044. Epub 2014 Mar 19.

11.

Genetic risk factors for major bleeding in patients treated with warfarin in a community setting.

Roth JA, Boudreau D, Fujii MM, Farin FM, Rettie AE, Thummel KE, Veenstra DL.

Clin Pharmacol Ther. 2014 Jun;95(6):636-43. doi: 10.1038/clpt.2014.26. Epub 2014 Feb 6.

12.

Perioperative use of selective serotonin reuptake inhibitors and risks for adverse outcomes of surgery.

Auerbach AD, Vittinghoff E, Maselli J, Pekow PS, Young JQ, Lindenauer PK.

JAMA Intern Med. 2013 Jun 24;173(12):1075-81. doi: 10.1001/jamainternmed.2013.714.

13.

Identifying the risks of anticoagulation in patients with substance abuse.

Efird LM, Miller DR, Ash AS, Berlowitz DR, Ozonoff A, Zhao S, Reisman JI, Jasuja GK, Rose AJ.

J Gen Intern Med. 2013 Oct;28(10):1333-9. doi: 10.1007/s11606-013-2453-x. Epub 2013 Apr 26.

14.

Use and safety of heparin-free maintenance hemodialysis in the USA.

Shen JI, Mitani AA, Chang TI, Winkelmayer WC.

Nephrol Dial Transplant. 2013 Jun;28(6):1589-602. doi: 10.1093/ndt/gft067. Epub 2013 Apr 5.

15.

Rates of hemorrhage during warfarin therapy for atrial fibrillation.

Gomes T, Mamdani MM, Holbrook AM, Paterson JM, Hellings C, Juurlink DN.

CMAJ. 2013 Feb 5;185(2):E121-7. doi: 10.1503/cmaj.121218. Epub 2012 Nov 26.

16.

Vascular disease in women: comparison of diagnoses in hospital episode statistics and general practice records in England.

Wright FL, Green J, Canoy D, Cairns BJ, Balkwill A, Beral V; Million Women Study Collaborators.

BMC Med Res Methodol. 2012 Oct 23;12:161. doi: 10.1186/1471-2288-12-161.

17.

A population-based assessment of the drug interaction between levothyroxine and warfarin.

Pincus D, Gomes T, Hellings C, Zheng H, Paterson JM, Mamdani MM, Juurlink DN.

Clin Pharmacol Ther. 2012 Dec;92(6):766-70. doi: 10.1038/clpt.2012.171. Epub 2012 Oct 24.

18.

Effectiveness of a novel and scalable clinical decision support intervention to improve venous thromboembolism prophylaxis: a quasi-experimental study.

Umscheid CA, Hanish A, Chittams J, Weiner MG, Hecht TE.

BMC Med Inform Decis Mak. 2012 Aug 31;12:92. doi: 10.1186/1472-6947-12-92.

19.

A systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative data.

Andrade SE, Harrold LR, Tjia J, Cutrona SL, Saczynski JS, Dodd KS, Goldberg RJ, Gurwitz JH.

Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:100-28. doi: 10.1002/pds.2312. Review.

20.

Dabigatran: review of pharmacology and management of bleeding complications of this novel oral anticoagulant.

Ganetsky M, Babu KM, Salhanick SD, Brown RS, Boyer EW.

J Med Toxicol. 2011 Dec;7(4):281-7. doi: 10.1007/s13181-011-0178-y. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk